Details

Autor(en) / Beteiligte

• Ma, Junhao
• Mao, Zhuochao
• Yao, Yunjin
• Lu, Yimin
• Wang, Haohao
• Yang, Yan
• Yang, Jun
• Wang, Weibin
• Teng, Lisong

Titel

Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism

Ist Teil von

• BMC surgery, 2021-09, Vol.21 (1), p.1-335, Article 335

Ort / Verlag

London: BioMed Central Ltd

Erscheinungsjahr

2021

Link zum Volltext

Quelle

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

Beschreibungen/Notizen

• Abstract Background The coexistence of primary hyperparathyroidism and papillary thyroid carcinoma (PTC) is common and may be associative with more aggressive PTC, with higher rates of extrathyroidal extension and multicentricity. However, it is unclear whether secondary hyperparathyroidism (SHPT) is associated with more invasive PTC in terms of morbidity, tumor pathological characteristics, and prognosis. The aim of this study was to evaluate the rate and tumor characteristics of PTC in patients with SHPT. Methods A total of 531 patients diagnosed with SHPT who underwent surgery from August 2013 to December 2018 at the First Affiliated Hospital of Zhejiang University were evaluated retrospectively. Patient demographics, surgical records, and follow-up information were recorded and analyzed. Control subjects were matched to the enrolled patients in a 1:4 ratio in terms of age, sex and pathological subtype. Results Among the 531 patients with SHPT who underwent surgery, 34 had coexisting PTC and PTC + SHPT (6.4%). The mean tumor diameter in the PTC + SHPT group was smaller than that in the PTC group (5.57 mm vs 9.00 mm, p  < 0.001). The proportion of papillary thyroid micro-carcinoma in the PTC + SHPT group was significantly higher than that in the PTC group (29 [85.29%] vs. 86[63.24%], p  = 0.014). There were no statistically significant differences between groups in terms of tumor multicentricity (15 [44.12%] vs 39 [28.68%], p  = 0.066), tumor bilaterality (9 [26.47%] vs. 29 [21.32%], p  = 0.499), tumor extrathyroidal extension (2 [5.88%] vs. 19 [13.97%], p  = 0.255), or lymph node (LN) metastasis rate (12 [35.29%] vs. 49 [36.03%], p  = 1.000). However, the PTC + SHPT and PTC groups were significantly different in terms of contralateral thyroidectomy (10 [29.41%] vs. 70 [51.47%], p  = 0.023) and lymph node dissection (22 [64.71%] vs. 125 [91.91%], p  < 0.001).There was no significant difference between the PTC + SHPT and PTC groups in terms of prognostic staging (33 [97.06%] vs. 122 [89.71%], p  = 0.309) or recurrence (mean follow-up time: 36 months vs. 39 months, p  = 0.33). Conclusions The prevalence of PTC is high in patients with SHPT; compared with PTC in the general population, most papillary thyroid carcinomas with SHPT are occult thyroid carcinomas and present no significant difference in terms of tumor pathological features and prognostic staging. It is necessary for surgeons to perform more adequate preoperative examination and be more careful during surgery to avoid missing the coexistence of PTC in patients with SHPT.